vs
AVALON HOLDINGS CORP（AWX）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是AVALON HOLDINGS CORP的1.7倍（$35.5M vs $21.5M），AVALON HOLDINGS CORP净利率更高（-1.7% vs -304.2%，领先302.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 21.7%），AVALON HOLDINGS CORP自由现金流更多（$-166.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 6.7%）
阿瓦隆山游戏公司是一家专业出版兵棋推演与策略桌游的游戏企业，业务也涵盖微缩兵棋规则、角色扮演游戏及体育模拟类游戏的出版。该公司隶属于孩之宝，在孩之宝旗下的游戏事业部开展运营。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
AWX vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.7倍
$21.5M
营收增速更快
RXRX
高出660.0%
21.7%
净利率更高
AWX
高出302.6%
-304.2%
自由现金流更多
AWX
多$47.2M
$-47.3M
两年增速更快
RXRX
近两年复合增速
6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.5M | $35.5M |
| 净利润 | $-356.0K | $-108.1M |
| 毛利率 | 17.1% | 59.8% |
| 营业利润率 | 0.4% | -304.8% |
| 净利率 | -1.7% | -304.2% |
| 营收同比 | 21.7% | 681.7% |
| 净利润同比 | 28.4% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWXRXRX
| Q4 25 | $21.5M | $35.5M | ||
| Q3 25 | $25.7M | $5.2M | ||
| Q2 25 | $20.3M | $19.2M | ||
| Q1 25 | $16.1M | $14.7M | ||
| Q4 24 | $17.6M | $4.5M | ||
| Q3 24 | $24.2M | $26.1M | ||
| Q2 24 | $23.1M | $14.4M | ||
| Q1 24 | $18.9M | $13.8M |
净利润AWXRXRX
| Q4 25 | $-356.0K | $-108.1M | ||
| Q3 25 | $1.9M | $-162.3M | ||
| Q2 25 | $274.0K | $-171.9M | ||
| Q1 25 | $-1.5M | $-202.5M | ||
| Q4 24 | $-497.0K | $-178.9M | ||
| Q3 24 | $1.8M | $-95.8M | ||
| Q2 24 | $954.0K | $-97.5M | ||
| Q1 24 | $-979.0K | $-91.4M |
毛利率AWXRXRX
| Q4 25 | 17.1% | 59.8% | ||
| Q3 25 | 23.7% | -183.8% | ||
| Q2 25 | 20.6% | -4.9% | ||
| Q1 25 | 14.8% | -48.0% | ||
| Q4 24 | 17.5% | -181.4% | ||
| Q3 24 | 24.6% | 53.7% | ||
| Q2 24 | 22.1% | 36.2% | ||
| Q1 24 | 16.2% | 19.1% |
营业利润率AWXRXRX
| Q4 25 | 0.4% | -304.8% | ||
| Q3 25 | 9.1% | -3327.6% | ||
| Q2 25 | 3.7% | -916.8% | ||
| Q1 25 | -7.2% | -1297.9% | ||
| Q4 24 | -0.8% | -4042.4% | ||
| Q3 24 | 9.4% | -377.1% | ||
| Q2 24 | 6.3% | -697.4% | ||
| Q1 24 | -2.7% | -698.4% |
净利率AWXRXRX
| Q4 25 | -1.7% | -304.2% | ||
| Q3 25 | 7.4% | -3135.3% | ||
| Q2 25 | 1.4% | -894.2% | ||
| Q1 25 | -9.3% | -1373.3% | ||
| Q4 24 | -2.8% | -3935.5% | ||
| Q3 24 | 7.6% | -367.5% | ||
| Q2 24 | 4.1% | -676.6% | ||
| Q1 24 | -5.2% | -662.4% |
每股收益（稀释后）AWXRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $38.4M | $1.1B |
| 总资产 | $87.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资AWXRXRX
| Q4 25 | $4.1M | $743.3M | ||
| Q3 25 | $4.6M | $659.8M | ||
| Q2 25 | $3.7M | $525.1M | ||
| Q1 25 | $1.3M | $500.5M | ||
| Q4 24 | $2.8M | $594.4M | ||
| Q3 24 | $3.9M | $427.6M | ||
| Q2 24 | $3.8M | $474.3M | ||
| Q1 24 | $1.2M | $296.3M |
总债务AWXRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益AWXRXRX
| Q4 25 | $38.4M | $1.1B | ||
| Q3 25 | $38.7M | $1.0B | ||
| Q2 25 | $36.8M | $919.1M | ||
| Q1 25 | $36.5M | $933.9M | ||
| Q4 24 | $38.0M | $1.0B | ||
| Q3 24 | $38.5M | $524.6M | ||
| Q2 24 | $36.7M | $584.4M | ||
| Q1 24 | $35.7M | $401.2M |
总资产AWXRXRX
| Q4 25 | $87.4M | $1.5B | ||
| Q3 25 | $90.7M | $1.4B | ||
| Q2 25 | $88.1M | $1.3B | ||
| Q1 25 | $87.6M | $1.3B | ||
| Q4 24 | $86.2M | $1.4B | ||
| Q3 24 | $89.1M | $726.5M | ||
| Q2 24 | $91.7M | $775.9M | ||
| Q1 24 | $90.6M | $557.8M |
负债/权益比AWXRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-166.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -0.8% | -133.1% |
| 资本支出强度资本支出/营收 | 2.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.1M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流AWXRXRX
| Q4 25 | $278.0K | $-46.1M | ||
| Q3 25 | $1.5M | $-117.4M | ||
| Q2 25 | $3.0M | $-76.4M | ||
| Q1 25 | $-982.0K | $-132.0M | ||
| Q4 24 | $-579.0K | $-115.4M | ||
| Q3 24 | $342.0K | $-59.2M | ||
| Q2 24 | $3.2M | $-82.2M | ||
| Q1 24 | $411.0K | $-102.3M |
自由现金流AWXRXRX
| Q4 25 | $-166.0K | $-47.3M | ||
| Q3 25 | $852.0K | $-117.6M | ||
| Q2 25 | $2.7M | $-79.6M | ||
| Q1 25 | $-1.4M | $-133.8M | ||
| Q4 24 | $-1.1M | $-116.7M | ||
| Q3 24 | $-660.0K | $-63.8M | ||
| Q2 24 | $2.9M | $-83.4M | ||
| Q1 24 | $56.0K | $-109.0M |
自由现金流率AWXRXRX
| Q4 25 | -0.8% | -133.1% | ||
| Q3 25 | 3.3% | -2272.5% | ||
| Q2 25 | 13.5% | -413.9% | ||
| Q1 25 | -8.5% | -907.4% | ||
| Q4 24 | -6.4% | -2567.7% | ||
| Q3 24 | -2.7% | -244.6% | ||
| Q2 24 | 12.4% | -578.5% | ||
| Q1 24 | 0.3% | -789.9% |
资本支出强度AWXRXRX
| Q4 25 | 2.1% | 3.5% | ||
| Q3 25 | 2.3% | 4.7% | ||
| Q2 25 | 1.4% | 16.4% | ||
| Q1 25 | 2.4% | 12.4% | ||
| Q4 24 | 3.1% | 28.6% | ||
| Q3 24 | 4.1% | 17.5% | ||
| Q2 24 | 1.5% | 8.2% | ||
| Q1 24 | 1.9% | 48.2% |
现金转化率AWXRXRX
| Q4 25 | — | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 3.35× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
